Clinical Trials Browser

Phase 2 × Pancreatic Adenocarcinoma × indusatumab × Clear all

NCT02202785 2017-05-15

A Study of MLN0264 in Patients With Pancreatic Cancer

Phase 2 Terminated

43 enrolled 22 charts

Gastrointestinal

Pancreatic Adenocarcinoma